Biomarin Pharmaceutical (BMRN) Revenue (2009 - 2026)
Biomarin Pharmaceutical's Revenue came in at $989.71 million for Q2 2026, up 19.9% from $825.41 million a year earlier and up 29.2% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Revenue (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported Revenue of $3.41 billion, up 11.2% year-over-year; for FY2025, it was $3.22 billion, up 12.9% from FY2024.
- Revenue has increased in each of the last four years, with a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- Going back by year, Revenue was $2.85 billion in FY2024 (+18.0%), $2.42 billion in FY2023 (+15.4%), $2.1 billion in FY2022 (+13.5%) and $1.85 billion in FY2021 (-0.8%).
- The Q2 2026 figure represents the highest quarterly Revenue in data going back to Q2 2009.
- Year-over-year, Revenue has increased for 18 consecutive quarters, with growth averaging 14.8% over the last eight quarters.
- The fastest year-over-year change in Revenue over five years came in Q3 2024 (growth of 28.3%), and the weakest in Q3 2021 (a decline of 14.3%).
- Business Quant data shows BMRN's Revenue at $766.21 million (Q1 2026), $874.57 million (Q4 2025) and $776.13 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Biomarin Pharmaceutical | 11.59 Bn | 5.45 Bn | 786.91 Mn | 989.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 989.71 Mn |
| Mar 31, 2026 | 766.21 Mn |
| Dec 31, 2025 | 874.57 Mn |
| Sep 30, 2025 | 776.13 Mn |
| Jun 30, 2025 | 825.41 Mn |
| Mar 31, 2025 | 745.15 Mn |
| Dec 31, 2024 | 747.31 Mn |
| Sep 30, 2024 | 745.74 Mn |
| Jun 30, 2024 | 712.03 Mn |
| Mar 31, 2024 | 648.83 Mn |
| Dec 31, 2023 | 646.21 Mn |
| Sep 30, 2023 | 581.33 Mn |
| Jun 30, 2023 | 595.28 Mn |
| Mar 31, 2023 | 596.42 Mn |
| Dec 31, 2022 | 537.54 Mn |
| Sep 30, 2022 | 505.34 Mn |
| Jun 30, 2022 | 533.80 Mn |
| Mar 31, 2022 | 519.36 Mn |
| Dec 31, 2021 | 449.81 Mn |
| Sep 30, 2021 | 408.74 Mn |
API Access
Biomarin Pharmaceutical Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();